Evidence map›Paper›PMID 42291424›Full record

ArticlePeerJ2026

Marutpong Panya, Phairo Saenwang, Pawana Panomket, Uthai Unphim

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marutpong PanyaResearch Group for Biomedical Research and Innovative Development (RG-BRID), College of Medicine and Public Health, Ubon Ratchathani University, Warinchamrap, Ubon Ratchathani, Thailand.
Phairo SaenwangResearch Group for Biomedical Research and Innovative Development (RG-BRID), College of Medicine and Public Health, Ubon Ratchathani University, Warinchamrap, Ubon Ratchathani, Thailand.
Pawana PanomketResearch Group for Biomedical Research and Innovative Development (RG-BRID), College of Medicine and Public Health, Ubon Ratchathani University, Warinchamrap, Ubon Ratchathani, Thailand.
Uthai UnphimFaculty of Management Science, Ubon Ratchathani University, Warinchamrap, Ubon Ratchathani, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Edible mushroom polysaccharides are recognized as prebiotics that influence gut microbiota composition and host health. However, the effects of the polysaccharides from Methods: Species identification of the two mushroom isolates (PB1 and LP1) was performed using molecular techniques. Cultivated mushrooms served as a source of polysaccharides, which were extracted using a combination of sonication and hot water. The composition of crude polysaccharides, including total carbohydrates, reducing sugars, proteins, and phenolic compounds, was analyzed. These extracts were subjected to simulated gastrointestinal digestion and used as substrates in batch fermentation inoculated with human fecal slurry. The bacterial communities in the treatment groups were identified and analyzed using 16S rRNA gene amplicon sequencing. Results: PB1 and LP1 were identified as Conclusions: Crude polysaccharides from cultivated

Indexed as

BacteriaGastrointestinal MicrobiomeLentinulaPolysaccharidesFecesFermentationHumansPrebioticsRNA, Ribosomal, 16SPolysaccharidesPrebioticsRNA, Ribosomal, 16SHuman fecal bacterial communityIn vitro fecal fermentationLentinus polychrousLentinus squarrosulusPolysaccharidePrebiotic

Identifiers

PMID42291424
PMCPMC13264279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.